Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy

Lupus nephritis (LN) occurs in up to 60% of systemic lupus erythematosus patients. Combination therapy involving a corticosteroid and cyclophosphamide or mycophenolate mofetil (MMF) has been a standard therapy for LN. However, clinicians generally prefer to minimize steroid use in LN treatment. We h...

Descripción completa

Detalles Bibliográficos
Autores principales: Nawata, Takashi, Kubo, Makoto, Fujii, Shohei, Shiragami, Kosaku, Ikegami, Tadayoshi, Kobayashi, Shigeki, Hisano, Satoshi, Yano, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096032/
https://www.ncbi.nlm.nih.gov/pubmed/29491296
http://dx.doi.org/10.2169/internalmedicine.0304-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096032/
https://www.ncbi.nlm.nih.gov/pubmed/29491296
http://dx.doi.org/10.2169/internalmedicine.0304-17

Ejemplares similares